ACADIAN ASSET MANAGEMENT LLC

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 916542 Boston, MA

Position in FDMT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,175,148

+$1,987,934 QoQ

Shares Held

163,545

+713.3% QoQ

Ownership

0.227%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#42

of 158 holders

Holding Since

Jun 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $730,930,536 across 167 Biotechnology names. FDMT ranks #47 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,664,999	$188,744,286
2	REGN	Regeneron Pharmaceuticals, Inc.	157,440	$98,170,137
3	IMCR	Immunocore Holdings plc	1,209,894	$38,414,134
4	RIGL	Rigel Pharmaceuticals Inc	591,686	$23,146,756
5	EXEL	Exelixis, Inc.	421,444	$22,930,768
6	VRTX	Vertex Pharmaceuticals Inc / Ma	42,122	$20,923,261
7	TBPH	Theravance Biopharma, Inc.	1,174,910	$19,973,470
8	PRTA	Prothena Corp Public Ltd Co	2,010,645	$19,684,214

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,175,148	163,545	+713.3%	Shares	Defined	2026-08-13
2026-03-31	$187,214	20,109	-33.3%	Shares	Defined	2026-05-13
2025-12-31	$225,982	30,131	-45.3%	Shares	Defined	2026-02-10
2025-09-30	$478,827	55,101	-83.3%	Shares	Defined	2025-11-13
2025-06-30	$1,226,492	330,591	-17.5%	Shares	Defined	2025-08-07
2025-03-31	$1,293,957	400,606	+1103.4%	Shares	Defined	2025-05-21
2024-12-31	$185,419	33,289	-41.2%	Shares	Defined	2025-02-11
2022-09-30	$454,999	56,592	-40.4%	Shares	Defined	2022-11-14
2022-06-30	$662,813	94,959	—	Shares	Defined	2022-08-09
No filing history on record for this holder in this stock.